This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Thédrez, P. Articles by Chatal, J.-F. Search for Related Content PubMed PubMed Citation Articles by Thédrez, P. Articles by Chatal, J.-F.

Biodistribution of Indium-111-labeled OC 125 Monoclonal Antibody after Intraperitoneal Injection in Nude Mice Intraperitoneally Grafted with Ovarian Carcinoma

Unité 211 INSERM, Faculté de Médecine, 1 rue Gaston Veil, Nantes, France [P. T., J. F. G., M. K., J. F. C.]; Compagnie ORIS Industrie, Gif sur Yvette, France [J. C. S., D. G., D. N.]; and D.A.M.R.I. Gif sur Yvette, France [J. P. S.]

The purpose of this work was to study the biodistribution of ¹¹¹Inlabeled OC 125 monoclonal antibody (MAb) with known affinity for ovarian carcinomas in a nude mouse model grafted i.p. with a human ovarian cancer (NIH:OVCAR-3). Tumor uptake 24 h after i.p. injection was higher with intact ¹¹¹In-labeled OC 125 MAb (28 ± 7.44%ID/g) than with ¹¹¹In-nonspecific immunoglobulin (6.86 ± 1.35%ID/g). The kinetics of tumor uptake also differed, showing a plateau followed by a drop at Day 7 with ¹¹¹In-OC 125 MAb and a decrease beginning at 24 h with ¹¹¹In-nonspecific immunoglobulin. Tumor-to-normal tissue ratios ranged between 29.91 ± 11.85 and 0.68 ± 0.15 with ¹¹¹In-OC 125 MAb and between 4.50 ± 1.06 and 0.53 ± 0.04 with ¹¹¹In-nonspecific immunoglobulin according to the normal tissues and the time points considered. Tumor uptake 2 h after injection was the same for F(ab')₂ fragments as for intact MAb, whereas maximum uptake at 24 h (18.76 ± 4.62%ID/g) was lower and was followed by a decrease at Day 4. Tumor-to-normal tissue ratios were in the same range, except for the tumor to blood ratio which was higher and the tumor to kidney ratio which was lower at 24 and 96 h. Maximum tumor uptake was higher after i.p. (30.77 ± 4.76%ID/g) than i.v. (14.59 ± 2.70%ID/g) injection. Instead of attaining the plateau noted after i.p. injection, tumor uptake after i.v. injection remained low at 2 h (2.11 ± 1.66%ID/g), reaching its peak only after 96 h. ¹³¹I-OC 125 injected i.p., which reached maximum tumor uptake at 2 h (13.53 ± 4.25%ID/g), showed tumor-to-tissue ratios ranging between 15.98 ± 2.63 and 0.96 ± 0.86, i.e., not very different from those with ¹¹¹In. After i.p. injection of a radiolabeled colloid solution, maximum tumor uptake was reached at 96 h (20.22 ± 5.35%ID/g), but with very high nonspecific uptake in liver (31.06 ± 6.22%ID/g) and spleen (55.23 ± 14.11%ID/g). These results indicate high, selective tumor uptake of ¹¹¹In-OC 125 after i.p. injection and demonstrate the feasibility of i.p. radioimmunotherapy of ovarian carcinomas.

¹ To whom requests for reprints should be addressed, at Unité 211 INSERM, Faculté de Médecine 1, Rue Gaston Veil, 44035 Nantes Cédex 01, France.

Received 9/28/88. Revised 2/24/89. Accepted 3/ 6/89.

This article has been cited by other articles:

				D. M. Goldenberg Adjuvant and Combined Radioimmunotherapy: Problems and Prospects on the Road to Minerva J. Nucl. Med., November 1, 2006; 47(11): 1746 - 1748. [Full Text] [PDF]

				N. Sato, H. Kobayashi, T. Saga, Y. Nakamoto, T. Ishimori, K. Togashi, Y. Fujibayashi, J. Konishi, and M. W. Brechbiel Tumor Targeting and Imaging of Intraperitoneal Tumors by Use of Antisense Oligo-DNA Complexed with Dendrimers and/or Avidin in Mice Clin. Cancer Res., November 1, 2001; 7(11): 3606 - 3612. [Abstract] [Full Text] [PDF]